Finance

Beta
Lists
082800:KOSDAQ
Vivozon Pharmaceutical Co Ltd
၃,၂၅၀.၀၀ ₩
-၁၀.၁၀%
(-၃၆၅.၀၀) 1D
ဇွန် ၁၈, GMT+၉ ၁၅:၃၀:၂၅  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 082800...
Open
၃,၆၁၅ ₩
High
၃,၆၁၅ ₩
Low
၃,၂၃၅ ₩
Mkt. cap
ဋေ ၁.၉၇ သ
Avg. vol.
၁.၅၇ သန်း
Volume
၁.၀၅ သန်း
52-wk high
၈,၂၇၅ ₩
52-wk low
၂,၁၅၀ ₩
EPS
-၆၅၄ ₩
Shares outstanding
၆.၀၇ ကုဋေ
No. of employees
၃၀၇
Open
၃,၆၁၅ ₩
High
၃,၆၁၅ ₩
Low
၃,၂၃၅ ₩
Mkt. cap
ဋေ ၁.၉၇ သ
Avg. vol.
၁.၅၇ သန်း
Volume
၁.၀၅ သန်း
52-wk high
၈,၂၇၅ ₩
52-wk low
၂,၁၅၀ ₩
EPS
-၆၅၄ ₩
Shares outstanding
၆.၀၇ ကုဋေ
No. of employees
၃၀၇
News stories
From sources across the web
Barchart.com
Barchart.com
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
Is Loews Stock Underperforming the S&P 500?
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၅၃ မိနစ်
OpenPayd merger with Titan (TACH) targets Nasdaq listing, >$1B equity value
CNBC
CNBC
·
ပြီးခဲ့သည့် ၃ နာရီ
Bonkers SpaceX stats that show how staggering the money movement has been
About Vivozon Pharmaceutical Co Ltd
CEO-
Employees၃၀၇
Founded၂၀၀၂
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
ဋေ ၁.၇၈ ထ
၆၇၅.၇၅ ဋေ
ဋေ ၁.၆၂ ထ
ဋေ ၁.၄၁ ထ
Cost of goods sold
၈၈၁.၉၈ ဋေ
၇၇၉.၅၃ ဋေ
၉၅၅.၉၃ ဋေ
၈၂၈.၉၅ ဋေ
Cost of revenue
၈၈၁.၉၈ ဋေ
၇၇၉.၅၃ ဋေ
၉၅၅.၉၃ ဋေ
၈၂၈.၉၅ ဋေ
Research and development expenses
၈၃.၉၄ ကုဋေ
၅၃.၄၃ ကုဋေ
၇၅.၅၁ ကုဋေ
၇၂.၈၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၀၅ ထ
၈၂၀.၈၈ ဋေ
၈၈၁.၇၁ ဋေ
၇၄၄.၈၂ ဋေ
Operating expense
ဋေ ၁.၁၇ ထ
၉၁၆.၅၀ ဋေ
ဋေ ၁.၀၄ ထ
၈၈၃.၆၁ ဋေ
Total operating expenses
ဋေ ၂.၀၅ ထ
ဋေ ၁.၇၀ ထ
ဋေ ၁.၉၉ ထ
ဋေ ၁.၇၁ ထ
Operating income
-၂၇၃.၁၃ ဋေ
-ဋေ ၁.၀၂ ထ
-၃၇၂.၈၇ ဋေ
-၃၀၁.၉၄ ဋေ
Other non operating income
-၂.၂၇ ကုဋေ
-၃.၇၆ သန်း
၂၇.၆၃ ကုဋေ
-၈၄.၇၀ ကုဋေ
EBT including unusual items
-၄၂၁.၈၅ ဋေ
-ဋေ ၁.၁၆ ထ
-ဋေ ၁.၂၇ ထ
-၅၅၅.၂၈ ဋေ
EBT excluding unusual items
-၄၂၂.၀၄ ဋေ
-ဋေ ၁.၁၆ ထ
-၆၁၄.၃၃ ဋေ
-၅၅၅.၄၅ ဋေ
Income tax expense
-
-
၄.၈၆ ကုဋေ
-
Effective tax rate
-
-
-၀.၃၈%
-
Other operating expenses
-
-
-
-
Net income
-၄၂၂.၄၂ ဋေ
-ဋေ ၁.၁၆ ထ
-ဋေ ၁.၂၈ ထ
-၅၅၅.၈၅ ဋေ
Net profit margin
-၂၃.၇၃%
-၁၇၂.၂၉%
-၇၈.၉၃%
-၃၉.၄၀%
Earnings per share
-
-
-
-
Interest and investment income
၃.၈၈ ကုဋေ
၁.၈၈ ကုဋေ
၉.၉၈ ကုဋေ
၄.၀၂ ကုဋေ
Interest expense
-၅၁.၁၃ ကုဋေ
-၅၅.၂၀ ကုဋေ
-၆၂.၉၉ ကုဋေ
-၇၄.၀၀ ကုဋေ
Net interest expenses
-၄၇.၂၅ ကုဋေ
-၅၃.၃၂ ကုဋေ
-၅၃.၀၁ ကုဋေ
-၆၉.၉၈ ကုဋေ
Depreciation and amortization charges
၁၉.၆၀ ကုဋေ
၂၀.၂၆ ကုဋေ
၁၉.၆၅ ကုဋေ
၁၉.၁၄ ကုဋေ
EBITDA
-၁၇၀.၃၂ ဋေ
-၉၁၆.၉၂ ဋေ
-၂၄၄.၃၇ ဋေ
-၁၇၄.၉၉ ဋေ
Gain or loss from assets sale
-၁.၉၂ သန်း
-၃.၉၃ သိန်း
၉.၁၈ ကုဋေ
-၁.၆၅ သန်း
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more